M. V. Peeters

PET/CT with 18F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease.

P. Elkhuizen, B. Koolen, V. Noort, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure

S. Rodenhuis, S. Linn, J. Wesseling, 2015, Breast Cancer Research and Treatment.

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

S. Rodenhuis, E. Rutgers, S. Linn, 2010, Annals of Surgical Oncology.

Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment).

K. K. van de Vijver, E. van Werkhoven, G. Sonke, 2018, Breast.

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

S. Rodenhuis, E. Rutgers, J. Wesseling, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics

S. Rodenhuis, P. Nederlof, J. Wesseling, 2012, Breast Cancer Research and Treatment.

Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancer.

E. van Werkhoven, P. Elkhuizen, G. Sonke, 2020, The British journal of surgery.

Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands

R. Tollenaar, M. Mureau, M. Jensen, 2020, Breast Cancer Research and Treatment.

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy.

M. J. van de Vijver, S. Rodenhuis, P. Nederlof, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.

H. Kuerer, M. Golatta, G. Rauch, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

The intraoperative assessment of sentinel nodes - Standards and controversies.

E. Rutgers, M. V. Vrancken Peeters, M. V. D. van der Noordaa, 2017, Breast.

Radioactive seed localization in breast cancer treatment

J. Sonke, T. Alderliesten, C. Loo, 2016, British Journal of Surgery.